Evaluation of the efficacy and safety of TAS0313 in adults with recurrent glioblastoma

BACKGROUND: TAS0313 is a multi-epitope long peptide vaccine targeting several cancer-associated antigens highly expressed in multiple cancer types, including glioblastoma (GBM). This cohort of a Phase 2 part evaluated the efficacy and safety of TAS0313 in patients with GBM. METHODS: TAS0313 (27 mg)...

Descripción completa

Detalles Bibliográficos
Autores principales: Narita, Yoshitaka, Okita, Yoshiko, Arakawa, Yoshiki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9519730/
https://www.ncbi.nlm.nih.gov/pubmed/35377001
http://dx.doi.org/10.1007/s00262-022-03184-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9519730/
https://www.ncbi.nlm.nih.gov/pubmed/35377001
http://dx.doi.org/10.1007/s00262-022-03184-7

Ejemplares similares